The Europe ENT Devices Market would witness market growth of 5.1% CAGR during the forecast period (2022-2028).
Adenoidectomy and tonsillectomy, ear surgeries such as myringotomy tube insertion, stapedectomy, tympanoplasty, rhinoplasty, septoplasty, sinus surgery, Tracheotomy, laryngectomy, etc., are the most common ENT surgical procedures. To rectify malformations or injuries, ENT surgery is frequently employed in reconstructive and aesthetic procedures.
Ear, nose, and facial prostheses are now often utilized in head and neck cancer therapy as well as rehabilitation treatments following traumas. Finding a hearing aid can be easier if users are familiar with one of the most common types of devices such as behind-the-ear hearing aids. Although "behind the ear" (BTE) hearing aids are undoubtedly the most popular ones available today, they aren't appropriate for everyone.
Some factors influencing the market for ENT devices also include the development of new technologies that enable their sophisticated uses, the rise in chronic ear infections, an increase in life expectancy, and an increase in noise pollution. One of the most prevalent issues in patients, particularly in industrialized nations, is hearing impairment. Infections like measles, meningitis, and middle ear infections are also frequent causes of hearing loss in developing nations.
The UK's life sciences industry contributes significantly to the country's economy. It employs 256,100 people and has an annual revenue of £80.7 billion. Moreover, with over 2,000 businesses and more than 80% of them being small & medium-sized enterprises, the UK's medical technology sector employs 100,000 people and is the second-largest employer in Europe behind Germany (200,000 people).
The Germany market dominated the Europe ENT Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,069.4 million by 2028.The UK market is anticipated to grow at a CAGR of 4.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.9% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals & Ambulatory Surgical Centers, ENT Clinics and Homecare. Based on Product, the market is segmented into Surgical ENT Devices, Diagnostics ENT Devices, Hearing Implants, Hearing Implants and Nasal Splints. Based on Surgical ENT Devices Type, the market is segmented into ENT Hand Instruments, Sinus Dilation Devices, Otological Drill Burrs, Radiofrequency Handpieces and Others. Based on Diagnostic ENT Devices Type, the market is segmented into Rigid Endoscopes H2, Flexible Endoscopes, Robot Assisted Endoscope and Hearing Screening Device. Based on Rigid Endoscopes Type, the market is segmented into Sinuscope, Otoscopes and Others. Based on Flexible Endoscopes Type, the market is segmented into Bronchoscopes, Laryngoscopes and Nasopharyngoscopes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global ENT Devices Market will Hit $30.7 Billion by 2028, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Sonova Holding AG, GN Store Nord A/S, Ambu A/S, Stryker Corporation, Karl Storz SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Cochlear, Ltd., and Starkey Laboratories, Inc.
By End-use
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
